Clinical Trials Browser

OTHER_GOV × durvalumab × Gastrointestinal × Clear all

NCT04893252 2022-11-30

Vactosertib and Durvalumab in Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms